{
    "code": "02023382",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02023382",
    "time": "2021-03-19 04:24:11",
    "許可證字號": "衛署藥輸字第023382號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "111\/02\/06",
    "發證日期": "91\/02\/06",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202338208",
    "中文品名": "妥泰分散型膠囊５０毫克",
    "英文品名": "TOPAMAX SPRINKLE CAPSULES 50MG",
    "適應症": "用於成人及二歲以上兒童局部癲癇或併有LENNOX-GASTAUT症候群之癲癇及原發性全身性強直陣攣癲癇的輔助治療，用於PARTIAL ONSET SEIZURE病患之單一藥物治療、預防偏頭痛。",
    "劑型": "130膠囊劑",
    "包裝": "2-1000粒塑膠瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "TOPIRAMATE",
    "限制項目": "02輸　入",
    "申請商名稱": "1507401100  嬌生股份有限公司",
    "申請商地址": "台北市中山區民生東路三段2號10樓及11樓",
    "主製造廠": [
        {
            "製造廠名稱": "FPR0036000  JANSSEN ORTHO LLC",
            "製造廠廠址": "STATE ROAD 933 KM 0.1 MAMEY WARD GURABO PUERTO RICO, 00778, USA",
            "製造廠公司地址": "CILAG A.G., HOCHSTRASSE 201, CH-8205 SCHAFFHAUSEN, SWITZERLAND",
            "製造廠國別": "PUERTO RICO",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "6132061151  裕利股份有限公司",
            "製造廠廠址": "桃園市大園區和平里1鄰開和路91號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": "二級包裝廠"
        },
        {
            "製造廠名稱": "FIT0332000  JANSSEN-CILAG S.P.A.",
            "製造廠廠址": "VIA C. JANSSEN 04100 BORGO S. MICHELE-LATINA, ITALY",
            "製造廠公司地址": "VIA M. BUONARROTI 23 20093 COLOGNO MONZESE ITALY",
            "製造廠國別": "ITALY",
            "製程": "包裝"
        },
        {
            "製造廠名稱": "FUS0342000  CATALENT PHARMA SOLUTIONS LLC",
            "製造廠廠址": "1100 ENTERPRISE DRIVE, WINCHESTER, KENTUCKY 40391, U.S.A.",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": "中間體製造"
        }
    ],
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9200038300",
            "成分名稱": "TOPIRAMATE",
            "含量描述": "",
            "含量": "50.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "附件三_妥泰分散型膠囊_仿單v2101_20201228-110-01-12.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023382&Seq=036&Type=9"
        },
        {
            "title": "Topamax Sprinkle 50mg box-104-09-30(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023382&Seq=001&Type=8"
        }
    ]
}